Business & Industry

The pharmaceutical industry confronts a formidable obstacle that threatens to derail promising therapeutic candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new chemical entities in development pipelines, creating fundamental challenges for drug absorption and bioavailability...

Anti-Counterfeit Technologies Strengthening Pharma Security The pharmaceutical industry faces an unprecedented challenge from counterfeit medications that threaten patient safety, erode brand trust, and result in billions of dollars in annual losses. Anti-counterfeit pharma packaging has emerged as a critical defense...

The Food and Drug Administration (FDA), which is already reeling from the layoffs and leadership changes within the Trump Administration, has warned that the government shutdown is also going to delay or pause a significant amount of work at...

Chemify scales up operations at Health Innovation Hub Digital chemistry company Chemify is set to embark on the next phase of its business journey with a strategic relocation to Glasgow’s newest purpose-built life science facility, Health Innovation Hub (HiH). Chemify,...

Technology Transfer Models for Emerging Pharmaceutical Regions The global pharmaceutical landscape is experiencing a fundamental transformation as technology transfer models for emerging pharmaceutical regions reshape industry dynamics and create new opportunities for sustainable healthcare solutions. Emerging markets now account for...

Donald Trump’s new tariffs when it comes to pharmaceutical imports are not going to apply to countries having negotiated agreements with the U.S. that contain the provisions on drugs, as per a White House official, therefore delivering promised tariff...

After the FDA went on to state that it was taking on what it has understood to be misleading or deceptive direct-to-consumer pharmaceutical ads, the floodgates have gone on to open, and how? In the first few days post the announcement,...